Dr Kathryn Parsley, Associate Director of Regulatory Affairs at Boyds, has confirmed that she will be presenting at the Annual Gene and Cell Therapy Summit in Berlin this year.
The summit will focus the delivery of cost and quality efficient process development, manufacturing and commercialisation of cell and gene therapies.
Dr Parsley will be presenting a case study on the regulatory challenges and practicalities of working with genetically modified organisms, an area in which she has extensive experience.
The two-day summit will take place on the 5-6 June 2019. For more information, click here.